Tracey Walker, Contributing Editor
Knowledge of MATs key to overcoming opioid abuse challenges
The biggest challenge in tackling opioid abuse is lack of awareness and understanding of addictive diseases, as well as misinformation and negative perceptions of medication-assisted therapies (MATs), according to a recent opinion article published in the New England Journal of Medicine.
Pfizer wants to acquire AstraZeneca
Pfizer announced its interest publicly in acquiring AstraZeneca and reincorporating in Britain, the New York Times reported.
Advanced stomach cancer drug approved
FDA approved ramucirumab (Cyramza, Eli Lilly) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma.
Community-associated MRSA epidemic linked to fluoroquinolone usage
Since the late 1990s, USA300, a strain of methicillin-resistant Staphylococcus aureus (MRSA), has spread across the United States, contributing to an epidemic of community-associated [CA] MRSA. The strains can persist in residential homes after infections, and appear to be linked to high usage of fluoroquinolones, according to a study published in the Proceedings for the National Academy of Sciences.
Once-weekly GLP-1 injectable approved for type 2 diabetes
FDA has approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly subcutaneous injectable for the treatment of adults with type 2 diabetes.
Rxs for antipsychotics to treat ADHD on the rise for young in foster care
Nearly one-third of the ADHD-diagnosed foster-care youth received atypical antipsychotics regardless of age group.
Costly HCV drug combo cures 90% of non-cirrhotic patients
An eight-week regimen of ledipasvir-sofosbuvir was highly effective in treating non-cirrhotic HCV patients with genotype infection.
Pharmacist follow-up can reduce readmission rates of lower-risk Medicare patients
Study finds that targeting the pharmacy service to patients who are most likely to benefit is important.
FDA approves Merck’s Grastek for grass pollen allergy
The sublingual tablet provides a new treatment option for patients who decline allergy shots
FDA approves hand-held auto-injector for reversal of opioid overdose
Family members and caregivers can be ready to act swiftly if they suspect opioid overdose.


View Results